Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures

BACKGROUND: Outcomes following andexanet alfa reversal of factor Xa inhibitors in patients requiring urgent or emergent invasive procedures are lacking. This study aimed to describe efficacy and safety outcomes following andexanet alfa administration within 24 h of an invasive procedure. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradshaw, Paige Garber, Keegan, Shaun Patrick, Droege, Molly Elizabeth, Dykes, Nicole Jade Harger, Ernst, Neil Edward, Foertsch, Madeline Jane, Makley, Amy Teres, Mueller, Eric William, Philpott, Carolyn Dosen, Srinivasan, Vasisht, Winter, Jessica Brooke, Goodman, Michael D., Droege, Christopher Allen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826450/
https://www.ncbi.nlm.nih.gov/pubmed/36073083
http://dx.doi.org/10.1002/phar.2727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826450/
https://www.ncbi.nlm.nih.gov/pubmed/36073083
http://dx.doi.org/10.1002/phar.2727

Ejemplares similares